15 (Lansoprazole delayed release (orally disintegrating) 15 mg)
Pill imprint 15 has been identified as Lansoprazole delayed release (orally disintegrating) 15 mg.
Lansoprazole is used in the treatment of gerd; barrett's esophagus; stomach ulcer; erosive esophagitis; zollinger-ellison syndrome (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for 15 (Lansoprazole delayed release (orally disintegrating) 15 mg)
- Imprint:
-
15
- Strength:
- 15 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Rx and/or OTC
- Drug Class:
- Proton pump inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-7448
- Inactive Ingredients:
- aspartame
silicon dioxide
ethyl butyrate
ethyl isovalerate
acacia
hypromelloses
lactose
magnesium carbonate
magnesium stearate
corn starch
maltodextrin
methacrylic acid - ethyl acrylate copolymer (1:1) type a
methyl cinnamate
sucrose
magnesium silicate
titanium dioxide
triethyl citrate
More resources
- Lansoprazole delayed release (orally disintegrating) Side Effects
- Lansoprazole delayed release (orally disintegrating) and Pregnancy
- Lansoprazole delayed release (orally disintegrating) Drug Interactions
- Support Group Q & A
- 32 Reviews for Lansoprazole delayed release (orally disintegrating) - Add your own review/rating
Lansoprazole delayed release (orally disintegrating) is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
